Notified bodies must keep authorised rep agreements on their radar, says Team-NB
This article was originally published in Clinica
Executive Summary
Should notified bodies be auditing the EU authorised representatives of companies based outside the European Economic Area and if so, how? That is the question addressed in a draft position paper that has been put together by TEAM-NB, the European Association for Medical devices of Notified Bodies.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.